Renaissance Technologies - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,419
-64.4%
2,365,754
-22.9%
0.00%
-66.7%
Q2 2023$3,988
-29.9%
3,067,496
-5.1%
0.01%
-25.0%
Q1 2023$5,690
-14.5%
3,232,795
+52.5%
0.01%
-11.1%
Q4 2022$6,655
-99.9%
2,119,496
+27.2%
0.01%
-25.0%
Q3 2022$8,164,000
+37.0%
1,666,096
+15.7%
0.01%
+71.4%
Q2 2022$5,960,000
+34.4%
1,439,496
+88.6%
0.01%
+40.0%
Q1 2022$4,434,000
-30.5%
763,096
-10.3%
0.01%
-37.5%
Q4 2021$6,380,000
-3.7%
850,696
+15.7%
0.01%
-11.1%
Q3 2021$6,627,000
-5.1%
735,500
+26.1%
0.01%0.0%
Q2 2021$6,981,000
-28.6%
583,200
-25.2%
0.01%
-25.0%
Q1 2021$9,771,000
-51.6%
779,800
-39.7%
0.01%
-45.5%
Q4 2020$20,171,000
+61.0%
1,292,600
-2.5%
0.02%
+69.2%
Q3 2020$12,526,000
+1967.0%
1,325,491
+1878.3%
0.01%
+1200.0%
Q3 2019$606,000
-91.0%
67,000
-89.3%
0.00%
-83.3%
Q2 2019$6,751,000
-21.8%
626,800
-30.8%
0.01%
-25.0%
Q1 2019$8,636,000
+2114.4%
905,200
+3703.4%
0.01%
Q4 2017$390,000
-60.3%
23,800
-92.6%
0.00%
-100.0%
Q4 2016$982,000
-64.3%
321,819
-45.9%
0.00%
-60.0%
Q3 2016$2,753,000
+316.5%
594,500
+420.6%
0.01%
+400.0%
Q2 2016$661,000
-78.3%
114,200
-77.3%
0.00%
-83.3%
Q1 2016$3,050,000
+59.5%
504,064
+140.7%
0.01%
+50.0%
Q4 2015$1,912,000
-30.3%
209,400
-56.9%
0.00%
-42.9%
Q3 2015$2,743,000
+129.7%
486,352
+351.6%
0.01%
+133.3%
Q2 2015$1,194,000
+797.7%
107,697
+533.5%
0.00%
Q2 2013$133,00017,0000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders